Cargando…

Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers

Detalles Bibliográficos
Autores principales: Sugiyama, Aya, Kurisu, Akemi, Nagashima, Shintaro, Hando, Kiyomi, Saipova, Khilola, Akhmedova, Sayyora, Abe, Kanon, Imada, Hirohito, Hussain, Md Razeen Ashraf, Ouoba, Serge, E, Bunthen, Ko, Ko, Akita, Tomoyuki, Yamazaki, Shinichi, Yokozaki, Michiya, Tanaka, Junko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893206/
https://www.ncbi.nlm.nih.gov/pubmed/36732557
http://dx.doi.org/10.1038/s41598-023-28884-7
_version_ 1784881476605575168
author Sugiyama, Aya
Kurisu, Akemi
Nagashima, Shintaro
Hando, Kiyomi
Saipova, Khilola
Akhmedova, Sayyora
Abe, Kanon
Imada, Hirohito
Hussain, Md Razeen Ashraf
Ouoba, Serge
E, Bunthen
Ko, Ko
Akita, Tomoyuki
Yamazaki, Shinichi
Yokozaki, Michiya
Tanaka, Junko
author_facet Sugiyama, Aya
Kurisu, Akemi
Nagashima, Shintaro
Hando, Kiyomi
Saipova, Khilola
Akhmedova, Sayyora
Abe, Kanon
Imada, Hirohito
Hussain, Md Razeen Ashraf
Ouoba, Serge
E, Bunthen
Ko, Ko
Akita, Tomoyuki
Yamazaki, Shinichi
Yokozaki, Michiya
Tanaka, Junko
author_sort Sugiyama, Aya
collection PubMed
description
format Online
Article
Text
id pubmed-9893206
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98932062023-02-02 Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers Sugiyama, Aya Kurisu, Akemi Nagashima, Shintaro Hando, Kiyomi Saipova, Khilola Akhmedova, Sayyora Abe, Kanon Imada, Hirohito Hussain, Md Razeen Ashraf Ouoba, Serge E, Bunthen Ko, Ko Akita, Tomoyuki Yamazaki, Shinichi Yokozaki, Michiya Tanaka, Junko Sci Rep Author Correction Nature Publishing Group UK 2023-02-02 /pmc/articles/PMC9893206/ /pubmed/36732557 http://dx.doi.org/10.1038/s41598-023-28884-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
Sugiyama, Aya
Kurisu, Akemi
Nagashima, Shintaro
Hando, Kiyomi
Saipova, Khilola
Akhmedova, Sayyora
Abe, Kanon
Imada, Hirohito
Hussain, Md Razeen Ashraf
Ouoba, Serge
E, Bunthen
Ko, Ko
Akita, Tomoyuki
Yamazaki, Shinichi
Yokozaki, Michiya
Tanaka, Junko
Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers
title Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers
title_full Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers
title_fullStr Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers
title_full_unstemmed Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers
title_short Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers
title_sort author correction: seroepidemiological study of factors affecting anti-spike igg antibody titers after a two-dose mrna covid-19 vaccination in 3744 healthy japanese volunteers
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893206/
https://www.ncbi.nlm.nih.gov/pubmed/36732557
http://dx.doi.org/10.1038/s41598-023-28884-7
work_keys_str_mv AT sugiyamaaya authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT kurisuakemi authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT nagashimashintaro authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT handokiyomi authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT saipovakhilola authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT akhmedovasayyora authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT abekanon authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT imadahirohito authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT hussainmdrazeenashraf authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT ouobaserge authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT ebunthen authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT koko authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT akitatomoyuki authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT yamazakishinichi authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT yokozakimichiya authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers
AT tanakajunko authorcorrectionseroepidemiologicalstudyoffactorsaffectingantispikeiggantibodytitersafteratwodosemrnacovid19vaccinationin3744healthyjapanesevolunteers